Large international study finds nearly half of patients admitted with visible blood in urine receive no imaging, delaying ...

The American College of Physicians says the term ‘provider’ blurs lines between nurse practitioners and physicians, confuses ...

The manufacturer of the interleukin-23 inhibitor tildrakizumab (Ilumya), Sun Pharma, announced today that the FDA has ...

Integrative clinics reflect a broader movement to close the long-standing gap between cardiovascular medicine and mental ...

A valved holding chamber with high drug delivery performance may reduce wheezing severity and hospitalizations more ...

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on ...

Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...

Invented by users and refined by engineers, wheelchairs now span €200 hospital loans to €30,000 custom models — a spectrum ...

Patients with IBD may experience increased serum levels of vitamin D with supplementation, but improvement in disease ...

A laboratory abnormality during the evaluation of erectile dysfunction in a young man leads clinicians to identify ...

Oral anticoagulation alone is linked to lower risks for cardiovascular death and bleeding than adding an antiplatelet in ...

Despite a high degree of worry about COVID and experience with severe, long-lasting symptoms, high-risk patients often do not ...